1. Product Specifications & Comparative Analysis

2. Industrial Applications & Functional Advantages

Cosmetic Formulations

• Anti-inflammatory Action: Inhibits COX-2 and reduces PGE2 production by ≥40%
• Melanogenesis Control: 63% tyrosinase inhibition at 0.5% concentration
• Enhanced Bioavailability: 3.2x higher skin permeation vs. glycyrrhizic acid

Pharmaceutical Uses

• Ulcer Treatment: 89% reduction in gastric lesions (in vivo models)
• Dermatological Solutions: 72% efficacy in eczema symptom reduction

3. Formulation Protocol & Stability Management

4. Implementation Scenarios

Case A: O/W Emulsion System – Maintains 98% potency after 12-month accelerated stability testing
Case B: Transdermal Patches – Achieves steady 2.1μg/cm²/hr permeation rate
Case C: Liposomal Delivery – Encapsulation efficiency >91% with particle size <150nm

5. Verified Client Implementations

Client 1: Lumière Cosmetics (France)

• Application: Anti-redness serum (0.45% concentration)
• Results: 67% reduction in erythema index within 28 days
• Feedback: “Critical for sensitive skin formulations” – R&D Director

Client 2: DermaHealth Solutions (USA)

• Application: Post-procedure recovery cream
• Outcome: 41% faster healing vs. competitor products
• Testimonial: “Our clinical results improved dramatically” – Formulation Lead

6. Request Technical Documentation

Contact our formulation experts for:
• Batch-specific COA
• Stability test data
• Custom solubility solutions
Email: info@vivalr.com
Tel: (86) 15866781826